BR0308764A - Formulações em suspensão hfa contendo um anticolinérgico - Google Patents

Formulações em suspensão hfa contendo um anticolinérgico

Info

Publication number
BR0308764A
BR0308764A BR0308764-6A BR0308764A BR0308764A BR 0308764 A BR0308764 A BR 0308764A BR 0308764 A BR0308764 A BR 0308764A BR 0308764 A BR0308764 A BR 0308764A
Authority
BR
Brazil
Prior art keywords
formulations containing
anticholinergic
suspension formulations
hfa
hfa suspension
Prior art date
Application number
BR0308764-6A
Other languages
English (en)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28050989&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0308764(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of BR0308764A publication Critical patent/BR0308764A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"FORMULAçõES EM SUSPENSãO HFA CONTENDO UM ANTICOLINéRGICO". A presente invenção refere-se a formulações de gases propulsores contendo suspensões do monohidrato do brometo de (1<244>,2<225>,4<225>,5<244>,7<225>)-7-[(hidroxidi-2-tienilacetil) oxi]-9,9-dimetil-3-oxa-9-azoniatriciclo[3.3.10^ 2,4^]nonano cristalino.
BR0308764-6A 2002-03-28 2003-03-20 Formulações em suspensão hfa contendo um anticolinérgico BR0308764A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214263A DE10214263A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
PCT/EP2003/002898 WO2003082252A1 (de) 2002-03-28 2003-03-20 Hfa-suspensionsformulierungen enthaltend ein anticholinergikum

Publications (1)

Publication Number Publication Date
BR0308764A true BR0308764A (pt) 2005-01-11

Family

ID=28050989

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308764-6A BR0308764A (pt) 2002-03-28 2003-03-20 Formulações em suspensão hfa contendo um anticolinérgico

Country Status (26)

Country Link
EP (2) EP1695701B1 (pt)
JP (1) JP4480401B2 (pt)
KR (1) KR101066801B1 (pt)
CN (1) CN1329023C (pt)
AT (1) ATE339953T1 (pt)
AU (1) AU2003209743B2 (pt)
BR (1) BR0308764A (pt)
CA (1) CA2479640C (pt)
CY (1) CY1105543T1 (pt)
DE (2) DE10214263A1 (pt)
DK (1) DK1492513T3 (pt)
EA (1) EA007239B1 (pt)
EC (1) ECSP045321A (pt)
ES (1) ES2273020T3 (pt)
HR (1) HRP20040889B1 (pt)
IL (2) IL163697A0 (pt)
ME (1) ME00247B (pt)
MX (1) MXPA04009337A (pt)
NO (1) NO20044005L (pt)
NZ (1) NZ536043A (pt)
PL (1) PL371296A1 (pt)
PT (1) PT1492513E (pt)
RS (1) RS52178B (pt)
UA (1) UA78557C2 (pt)
WO (1) WO2003082252A1 (pt)
ZA (1) ZA200405638B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ552869A (en) † 2004-07-02 2010-06-25 Boehringer Ingelheim Int Aerosol suspension formulations containing TG 227 ea as a propellant, an ipratropium or tiotropium salt and a small amount of free water to stabilise the composition
TWI396541B (zh) * 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
GB201200504D0 (en) * 2011-12-19 2012-02-22 Teva Branded Pharmaceutical Prod R & D Inc An inhaler
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
WO2014064410A2 (en) * 2012-10-23 2014-05-01 Cipla Limited Pharmaceutical composition
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN107056629B (zh) * 2017-04-27 2019-04-30 河北科技大学 一种无水卤化胆碱及其衍生物单晶的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
CN1150890C (zh) * 1998-08-04 2004-05-26 杰格研究股份公司 药用气溶胶制剂
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
CN100519558C (zh) * 2000-10-12 2009-07-29 贝林格尔英格海姆法玛两合公司 结晶单水合物、其制备方法及其在制备药物组合中的用途
MXPA03003751A (es) * 2000-10-31 2004-10-15 Boehringer Ingelheim Pharma Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y corticoesteroides.
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

Also Published As

Publication number Publication date
HK1079091A1 (en) 2006-03-31
DE50305118D1 (de) 2006-11-02
HRP20040889A2 (en) 2004-12-31
YU85904A (sh) 2006-08-17
CN1329023C (zh) 2007-08-01
ZA200405638B (en) 2005-07-27
HRP20040889B1 (hr) 2012-11-30
ES2273020T3 (es) 2007-05-01
CA2479640C (en) 2010-09-28
NO20044005L (no) 2004-10-05
WO2003082252A1 (de) 2003-10-09
EP1695701B1 (de) 2015-01-07
KR101066801B1 (ko) 2011-09-22
EP1695701A3 (de) 2010-04-28
DE10214263A1 (de) 2003-10-16
IL163697A0 (en) 2005-12-18
AU2003209743B2 (en) 2008-03-06
PL371296A1 (en) 2005-06-13
EP1492513A1 (de) 2005-01-05
EP1695701A2 (de) 2006-08-30
EA200401190A1 (ru) 2005-04-28
JP2005529087A (ja) 2005-09-29
DK1492513T3 (da) 2006-12-18
IL163697A (en) 2011-03-31
EP1492513B1 (de) 2006-09-20
ATE339953T1 (de) 2006-10-15
UA78557C2 (en) 2007-04-10
ME00247B (me) 2011-05-10
MEP47408A (en) 2011-02-10
EA007239B1 (ru) 2006-08-25
RS52178B (sr) 2012-10-31
CY1105543T1 (el) 2010-07-28
KR20040098031A (ko) 2004-11-18
JP4480401B2 (ja) 2010-06-16
PT1492513E (pt) 2006-12-29
CA2479640A1 (en) 2003-10-09
AU2003209743A1 (en) 2003-10-13
MXPA04009337A (es) 2005-01-25
NZ536043A (en) 2005-09-30
CN1642534A (zh) 2005-07-20
ECSP045321A (es) 2005-01-28

Similar Documents

Publication Publication Date Title
BR0116444A (pt) Processo para a preparação de brometo de tiotrópio anticolinérgico
YU99703A (sh) Kristalni antiholinergik, postupak za njegovo pripremanje i njegova primena u proizvodnji leka
YU27303A (sh) Kristalni monohidrat, postupak za njegovo pripremanje i njegova primena za pripremanje leka
DK1401837T3 (da) Purinderivater som A2B-adenosinreceptorantagonister
PE20030759A1 (es) Uso de ureas de benzotiazoles
MXPA04000507A (es) Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, su preparacion y uso terapeutico.
AU2002246728A1 (en) Carboline derivatives
MXPA02012712A (es) N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas.
BRPI0110955B8 (pt) derivados de tropano composição farmacêutica, uso dos mesmos na fabricação de um medicamento bem como processo para a preparação dos mesmos.
ATE340796T1 (de) Dihydropyrrolo(1,2-aöindol- und tetrahydropyrido)1,2-aöindolderivate als prostaglandin rezeptor antagonisten
NO20045235L (no) Tetrahydropyranylsyklopentyltetrahydropyridopyridinmodulatorer med kjemokinreseptoraktivitet
AU2003228770A1 (en) Substituted pyrazolopyrimidines
BR0308764A (pt) Formulações em suspensão hfa contendo um anticolinérgico
AU2002249890A1 (en) Carboline derivatives
WO2003022209A3 (en) Crystalline forms of valacyclovir hydrochloride
NO20044545L (no) Piperidin-eller 8-aza-bicyklo[3.2.1.]okt-3-yl derivater som er nyttige som modulatorer for kemokireseptoraktivitet (spesielt CCR5)
ES2177583T3 (es) Nuevo compuesto tetraciclico.
BR0308709A (pt) Formulações em suspensão de hfa de um anidrato
TWI262921B (en) Selective antagonists of A2B adenosine receptors
AR086573A2 (es) Derivados de 5-(piridin-3-il)-1-azabiciclo[3,2,1]octano y octeno, su preparacion y su aplicacion en terapeutica
MXPA03009602A (es) Analogos de nociceptina.
MX2007005478A (es) Formulaciones de derivados de [1,4]diazepino[6,7,1-ij]quinolina.
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
EP1786815A4 (en) SPIRO COMPOUNDS AND METHOD FOR MODULATING CHEMOKIN RECEPTOR ACTIVITY
AU3217693A (en) Aminobenzoic acid derivatives

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: A61K 9/72, A61K 31/46, A61P 11/06

Ipc: A61K 9/72 (2011.01), A61K 31/46 (2011.01), A61P 11

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]